dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2022-03-08T14:08:22Z |
dc.date.available | 2022-03-08T14:08:22Z |
dc.date.issued | 2022-02-01 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica. Barcelona: Servei Català de la Salut; 2022. |
dc.identifier.uri | https://hdl.handle.net/11351/7124 |
dc.description | Chronic obstructive pulmonary disease; COPD; Triple therapy; Budesonide; Glycopyrronium bromide; Formoterol |
dc.description.abstract | Formoterol / glycopyrronium bromide / budesonide (FOR / GLIC / BUD) is a fixed-dose combination (CDF) of a long-acting beta-2-adrenergic agonist (LABA), a long-acting muscarinic antagonist (LAMA). and an inhaled corticosteroid (CI) at a medium dose. It is indicated for the maintenance treatment of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately controlled on the combination of an IC and a LABA or a combination of an LABA and a LAMA. The dosage is two inhalations twice a day using a pressurized cartridge inhaler (pMDI) |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Malalties obstructives - Tractament |
dc.subject | Pulmons - Malalties obstructives - Costos |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Outcome and Process Assessment (Health Care) |
dc.title | Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | evaluación de resultados y procesos (atención a la salud) |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |